Answers are grounded in this paper and cite their sources.
Knowledge on heparin-induced thrombocytopenia keeps increasing. Recent progress on diagnosis and management as well as several discoveries concerning its pathogenesis have been made. However, many aspects of heparin-induced thrombocytopenia remain partly unknown, and exact application of these new insights still need to be addressed. This article reviews the main new concepts in pathogenesis, diagnosis, and management of heparin-induced thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Marchetti et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: